Cargando…
Delivery strategies of amphotericin B for invasive fungal infections
Invasive fungal infections (IFIs) represent a growing public concern for clinicians to manage in many medical settings, with substantial associated morbidities and mortalities. Among many current therapeutic options for the treatment of IFIs, amphotericin B (AmB) is the most frequently used drug. Am...
Autores principales: | Wang, Xiaochun, Mohammad, Imran Shair, Fan, Lifang, Zhao, Zongmin, Nurunnabi, Md, Sallam, Marwa A., Wu, Jun, Chen, Zhongjian, Yin, Lifang, He, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424280/ https://www.ncbi.nlm.nih.gov/pubmed/34522599 http://dx.doi.org/10.1016/j.apsb.2021.04.010 |
Ejemplares similares
-
Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate
por: Chandrasekar, PH
Publicado: (2008) -
Evaluation of Hepatotoxicity with Treatment Doses of Flucytosine and Amphotericin B for Invasive Fungal Infections
por: Folk, Alexandra, et al.
Publicado: (2016) -
Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection
por: Yang, Zhiwen, et al.
Publicado: (2014) -
Orbital compartment syndrome following retrobulbar injection of amphotericin B for invasive fungal disease
por: Brodie, Frank L., et al.
Publicado: (2016) -
Amphotericin B-conjugated polypeptide hydrogels as a novel innovative strategy for fungal infections
por: Shu, Chang, et al.
Publicado: (2018)